Abbott Clinical Chemistry & Immunoassay Reagents/Analyzers

The Regional Health Contracting Office - Pacific, in support of MEDCOM, intends to make a sole source award to Abbott Laboratories, Inc for a firm fixed-price contract for Abbott Clinical Chemistry and Immunoassay Reagents and Analyzers at Tripler Army Medical Center, Hawaii.  The period of performance is on or about 01 October 2022 through 31 December 2022.  

The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.  Abbott Laboratories Inc is the only company to provide reagents and analyzers that have already been validated by the Tripler Army Medical Center’s Core Laboratory.

This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency.  All questions and responses concerning this notice shall be emailed to susan.m.fujita.civ@health.mil.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.